SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-047912
Filing Date
2023-04-21
Accepted
2023-04-20 18:00:44
Documents
13
Period of Report
2023-04-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2313121d1_8k.htm   iXBRL 8-K 37346
2 EXHIBIT 3.1 tm2313121d1_ex3-1.htm EX-3.1 158436
  Complete submission text file 0001104659-23-047912.txt   411565

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA uthr-20230420.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20230420_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20230420_pre.xml EX-101.PRE 22593
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2313121d1_8k_htm.xml XML 3613
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 23834117
SIC: 2834 Pharmaceutical Preparations